论文部分内容阅读
对于难治性急性白血病目前尚无有效治疗方案.国外有学者报告,大剂量甲基强的松龙(HDMP)合并阿糖胞苷(Ara—C)、阿霉素(ADR)(简称MAA方案)治疗儿童急性非淋巴细胞性白血病有一定疗效,为此,本文用MAA方案治疗5例成人难治性急性白血病,现报告如下:
There are currently no effective treatment options for refractory acute leukemia. Some foreign scholars have reported that high-dose methylprednisolone (HDMP) is combined with cytarabine (Ara-C) and adriamycin (ADR) (abbreviated as MAA). ) The treatment of acute non-lymphocytic leukemia in children has a certain effect. Therefore, this article uses MAA regimen to treat five cases of adult refractory acute leukemia. The report is as follows: